FCGR2A and infection: While counterintuitive, our results support the thesis raised by others [20] that certain NTD-binding mAbs, while mediating enhanced infection with SARS-CoV-2 in vitro, may have protective FcγR-effector functions in vivo, with the potential to drive immune selection and NTD sequence variability at this site.